Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03010176
Title Study of MK-1454 Alone or in Combination With Pembrolizumab in Participants With Advanced/Metastatic Solid Tumors or Lymphomas (MK-1454-001)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Merck Sharp & Dohme Corp.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ISR | GBR | FRA

Facility Status City State Zip Country Details
University of Alabama ( Site 0009) Birmingham Alabama 35294 United States Details
University of California San Francisco ( Site 0007) San Francisco California 94143 United States Details
UCSF ( Site 0015) San Francisco California 94158 United States Details
UCLA Medical Center ( Site 0005) Santa Monica California 90404 United States Details
Henry Ford Health System ( Site 0014) Detroit Michigan 48202 United States Details
Mount Sinai Hospital ( Site 0002) New York New York 10029 United States Details
Columbia University ( Site 0003) New York New York 10032 United States Details
UPMC Hillman Cancer Center ( Site 0013) Pittsburgh Pennsylvania 15232 United States Details
Mary Crowley Cancer Research Center ( Site 0001) Dallas Texas 75230 United States Details
Huntsman Cancer Institute ( Site 0004) Salt Lake City Utah 84112 United States Details
Institut Claudius Regaud ( Site 0051) Toulouse Cedex 9 Haute-Garonne 31059 France Details
Institut Gustave Roussy ( Site 0049) Villejuif Val-de-Marne 94805 France Details
Institut Curie ( Site 0050) Paris 75005 France Details
Rambam Medical Center ( Site 0041) Haifa 3109601 Israel Details
Sheba Medical Center ( Site 0040) Ramat Gan 5265601 Israel Details
Severance Hospital ( Site 0103) Seoul 03722 Korea, Republic of Details
Asan Medical Center ( Site 0104) Seoul 05505 Korea, Republic of Details
The Royal Marsden Foundation Trust ( Site 0031) London London, City Of SW3 6JJ United Kingdom Details
The Royal Marsden NHS Foundation Trust. ( Site 0032) Sutton Surrey SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field